Exforge (Novartis Pharmaceuticals Corporation)
Welcome to the PulseAid listing for the Exforge drug offered from Novartis Pharmaceuticals Corporation. This Calcium Channel Antagonists [MoA],Dihydropyridine Calcium Channel Blocker [EPC],Dihydropyridines [Chemical/Ingredient],Angiotensin 2 Receptor Antagonists [MoA],Angiotensin 2 Receptor Blocker [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Novartis Pharmaceuticals Corporation |
| NON-PROPRIETARY NAME: | amlodipine besylate and valsartan |
| SUBSTANCE NAME: | AMLODIPINE BESYLATE; VALSARTAN |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Calcium Channel Antagonists [MoA],Dihydropyridine Calcium Channel Blocker [EPC],Dihydropyridines [Chemical/Ingredient],Angiotensin 2 Receptor Antagonists [MoA],Angiotensin 2 Receptor Blocker [EPC] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET, FILM COATED |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2007-06-20 |
| END MARKETING DATE: | 0000-00-00 |
Exforge HUMAN PRESCRIPTION DRUG Details:
| Item Description | Exforge from Novartis Pharmaceuticals Corporation |
| LABELER NAME: | Novartis Pharmaceuticals Corporation |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 5; 160(mg/1; mg/1) |
| START MARKETING DATE: | 2007-06-20 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0078-0488_33fbb912-df47-4ddc-8d8f-e5fbd51939f8 |
| PRODUCT NDC: | 0078-0488 |
| APPLICATION NUMBER: | NDA021990 |
Other AMLODIPINE BESYLATE; VALSARTAN Pharmaceutical Manufacturers / Labelers:
